Thermo Fisher Scientific provides industry-leading pharma services solutions for drug development, clinical trial logistics and commercial manufacturing to customers through our Patheon brand. With more than 55 locations around the world, we provide integrated, end-to-end capabilities across all phases of development, including API, biologics, viral vectors, cGMP plasmids, formulation, clinical trials solutions, logistics services and commercial manufacturing and packaging. We give pharma and biotech companies of all sizes instant access to a global network of facilities and technical experts across the Americas, Europe, Asia and Australia. Our global leadership is built on a reputation for scientific and technical excellence. We offer integrated drug development and clinical services tailored to fit your drug development journey through our Quick to CareTM program. As a leading pharma services provider, we deliver unrivaled quality, reliability and compliance.

Together with our customers, we’re rapidly turning pharmaceutical possibilities into realities. In APAC, currently we have biologics manufacturing site based in Brisbane, Australia.  In 2022, we will expand our presence in APAC and launch Biologics and Sterile fill finish site in Hangzhou, China and Sterile fill finish site in Singapore.

For more information, please visit our booth.